Search
Proctitis
go.drugbank.com/conditions/DBCOND0011080Drugs: Aluminum subacetate · Balsam of Peru · Calcium carbonate · Esculin · Fluocortolone caproate · Fluocortolone pivalate +7 moreSynonyms: Other specified diseases of anus and rectumLatanoprost
go.drugbank.com/drugs/DB00654ApprovedInvestigational[A184493] It has been found to be well-tolerated and its use does not normally result in systemic adverse effects like other drugs used to treat elevated intraocular pressure, such as [Timolol]. … Latanoprost is a prodrug analog of prostaglandin F2 alpha that is used to treat elevated intraocular pressure (IOP). It was initially approved by the FDA in 1998.
Mixtures: Latanoprost and Timolol STADA 50mcg/ml + 5mg/ml Eye drops, PROSTACOM (LATANOPROST 0.05 MG/ML AND TIMOLOL 5MG/ML, EYE DROPS)Categories: latanoprost and netarsudil, latanoprost and dorzolamideCaplacizumab
go.drugbank.com/drugs/DB06081ApprovedInvestigationalCaplacizumab was developed by Ablynx, a Sanofi company and FDA approved on February 6, 2019,[L5302] and approved previously by the EU in October 2018 as a combination therapy with plasma exchange and immunosuppression … [A174634]In December 2025, the FDA expanded this indication to include pediatric patients aged 12 years and older with aTTP, in the same combination regimen.[L54958,L54963]
Categories: Amino Acids, Peptides, and Proteins, Blood and Blood Forming OrgansAmphetamine
go.drugbank.com/drugs/DB00182ApprovedIllicitInvestigationalAfter being proven to reduce drug-induced anesthesia and produce arousal and insomnia, amphetamine racemic mix was registered by Smith, Kline and French in 1935. … Amphetamine structure presents one chiral center and it exists in the form of dextro- and levo-isomers.[A18540] The first product of Smith, Kline and French was approved by the FDA on 1976.
Mixtures: Dextroamphetamine Saccharate and Amphetamine Aspartate and Dextroamphetamine Sulfate and Amphetamine Sulfate, Dextroamphetamine Saccharate and Amphetamine Aspartate and Dextroamphetamine Sulfate and Amphetamine SulfateCategories: Psychostimulants, Agents Used for ADHD and Nootropics, Serotonergic Drugs Shown to Increase Risk of Serotonin SyndromeEnzacamene
go.drugbank.com/drugs/DB11219ApprovedWhile its effects on the human reproductive system as an endocrine disruptor are being investigated, its use in over-the-counter and cosmetic products is approved by Health Canada. … Commonly known as 4-methylbenzylidene-camphor (4-MBC), enzacamene is a camphor derivative and an organic chemical UV-B filter.
Mixtures: But First Water, Natural Sun AQ Body and Family Mild Sun MilkCoagulation factor X human
go.drugbank.com/drugs/DB13148ApprovedInvestigationalCoagulation Factor X (Human), is a plasma-derived human blood coagulation factor is used by adults and children (aged 12 years and above) with hereditary Factor X deficiency. … Administration of coagulation Factor X from healthy donor serves to restore and achieve effective hemostasis.
Mixtures: OCTAPLEX POWDER AND SOLVENT FOR SOLUTION FOR INJECTION 500 IU, Octaplex Powder and Solvent for Solution for InfusionCategories: Enzymes and Coenzymes, Blood and Blood Forming OrgansDaclatasvir
go.drugbank.com/drugs/DB09102ApprovedInvestigationalWithdrawnIt exerts its antiviral action by preventing RNA replication and virion assembly via binding to NS5A, a nonstructural phosphoprotein encoded by HCV. … Daclatasvir is shown to target both the cis- and trans-acting functions of NS5A and disrupts the function of new HCV replication complexes by modulating the NS5A phosphorylation status [A19640].
Categories: Amino Acids, Peptides, and Proteins, daclatasvir, asunaprevir and beclabuvirProducts: DAKLINZA TABLET 30MG, DAKLINZA TABLET 60MGProliferative Diabetic Retinopathy (PDR)
go.drugbank.com/conditions/DBCOND0056889Drugs: RanibizumabSynonyms: Retinopathy co-occurrent and due to diabetes mellitus, Proliferative retinopathy co-occurrent and due to diabetes mellitusVenous Embolism
go.drugbank.com/conditions/DBCOND0133256Drugs: PhenprocoumonSynonyms: Acute embolism and thrombosis of unspecified veinAmivantamab
go.drugbank.com/drugs/DB16695ApprovedInvestigational[A235133] Amivantamab was granted FDA approval on 21 May 2021,[L34193] followed by the approval by the EMA on 9 December 2021 [L41474] and Health Canada on 30 March 2022. … non-small cell lung cancer (NSCLC) with epidermal growth factor receptor (EGFR) exon 20 insertion mutations, as detected by an FDA-approved test, whose disease has progressed on or after platinum-based
Categories: Amino Acids, Peptides, and Proteins, Antineoplastic and Immunomodulating Agents